Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxwell A Witt

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2012
Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreakMaxwell A Witt, Paul H Katz, David J Witt
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2013
Reply to Andre et alMaxwell A Witt, Paul H Katz, Elizabeth T Truong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 2013
Reply to Kiraly et alMaxwell A Witt, Paul H Katz, Elizabeth T Truong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2013
Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohortMaxwell A Witt, Larry Arias, Paul H Katz, et al.
Drugs|January 13, 2017
Eight- or 12-Week Treatment of Hepatitis C with Ledipasvir/Sofosbuvir: Real-World Experience in a Large Integrated Health SystemJennifer B Lai, Maxwell A Witt, Mary Patricia Pauly, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2012
Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreakMaxwell A Witt, Paul H Katz, David J Witt
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2013
Reply to Andre et alMaxwell A Witt, Paul H Katz, Elizabeth T Truong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 2013
Reply to Kiraly et alMaxwell A Witt, Paul H Katz, Elizabeth T Truong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2013
Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohortMaxwell A Witt, Larry Arias, Paul H Katz, et al.
Drugs|January 13, 2017
Eight- or 12-Week Treatment of Hepatitis C with Ledipasvir/Sofosbuvir: Real-World Experience in a Large Integrated Health SystemJennifer B Lai, Maxwell A Witt, Mary Patricia Pauly, et al.
Pageof 1